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Introduction: Patients with human immunodeficiency virus carry a significant risk of contracting opportunistic
infections. The worldwide increased incidence of tuberculosis has instituted pulmonary tuberculosis as an important
diagnostic consideration in patients with human immunodeficiency virus presenting with lower respiratory tract
infection. A positive result on the readily-available Ziehl-Neelsen stain usually leads to the initiation of antituberculous
treatment, since tuberculosis may exert a rapid and even fatal clinical progress in human immunodeficiency virus
coinfection. However, a number of other acid-fast bacteria might be implicated as offending pathogens. This case
highlights the importance of broadening the list of pathogens that can account for a positive Ziehl-Neelsen stain
in this select group of patients.
Case presentation: We describe the case of a 34-year-old, Albanian man with untreated human immunodeficiency
virus, presenting with clinical and radiologic signs of pulmonary tuberculosis and a positive Ziehl-Neelsen sputum
specimen, who was finally diagnosed with pulmonary infection by Rhodococcus equi.
Conclusions: Rhodococcus equi is a rare cause of pulmonary disease, even in patients with human immunodeficiency
virus, and a positive Ziehl-Neelsen sputum specimen often misleads clinicians to more common organisms such as
mycobacteria. A high index of suspicion, broadening the spectrum of optional pathogens, and effective communication
between clinicians and microbiologists can ensure an efficient diagnostic and therapeutic approach.
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Although opportunistic infections (OIs) in individuals
with human immunodeficiency virus (HIV) have become
rare in industrialized countries since the introduction of
highly active antiretroviral therapy, patients continue to
present with advanced HIV and HIV-related OIs [1].
Diagnosis of OIs in patients with HIV infection is a chal-
lenging medical task, in which effective clinical manage-
ment requires firstly, a high index of clinical suspicion* Correspondence: spiliopl@upatras.gr
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article, unless otherwise stated.and secondly, the determination of the offending oppor-
tunistic pathogen, which will guide the institution of
specific treatment in most cases.
Patients with HIV presenting with pulmonary infections
may suffer from common bacterial pneumonias (60%),
Pneumocystis jirovecii-associated pneumonia (20%), and
mycobacterial pneumonias (20%), mostly caused by Myco-
bacterium tuberculosis (MTB), and less frequently by non-
tuberculous mycobacteria (NTM), viral pneumonias (5%),
fungal pneumonias (2%), parasitic pneumonias (0.5%), and
multiple-pathogen pneumonia (7%) [2]. Intersection of
the HIV and tuberculosis (TB) epidemics has led to a sub-
stantial increase in global TB incidence. In a compatible
clinical course, pulmonary tuberculosis in a patient withntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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exert a rapid and even fatal clinical progress [3].
In patients with HIV who are suspected of having TB
by clinical and/or radiological criteria, the most import-
ant diagnostic tests are repeated sputum or bronchial
samples for smear and culture [4]. In this patient popu-
lation a positive smear for acid-fast bacilli (AFB), as
detected by the Ziehl-Neelsen stain (Z-N), is very spe-
cific of MTB, even in a setting with a high incidence of
M. avium complex that stains similarly [5]. Therefore, in
such cases, initiation of antituberculous treatment is the
usual practice while waiting upon specific culture results.
In this case report, we describe the case of a patient
with untreated HIV who presented with clinical and
radiological signs of pulmonary tuberculosis and a posi-
tive Z-N sputum specimen, who was finally diagnosed
with pulmonary infection by Rhodococcus equi, an acid-
fast, Gram-positive coccobacillus, which is increasingly
recognized as an opportunistic pathogen in immuno-
compromised patients.
Case presentation
A 34-year-old Albanian man was admitted to a
regional hospital presenting with dry cough, fever,
progressive dyspnea, night sweats, and a thick-walled
cavitary lesion of the left lung, associated with bilateral
pulmonary infiltrates on radiologic examination (Figure 1a
and b). He had been well in other aspects until 15 days
previous, except that he had lost 10kg in the last six
months. While in the emergency department, he tested
positive for HIV-1 infection and was referred to our
hospital.Figure 1 Chest X-ray (a) and contrast-enhanced computed tomograp
infiltrates located mainly at the lower lung lobes and a cavitary lesionHe had emigrated from Albania to Greece 10 years
previously and worked as a farmer. He resided with his
wife and two children, all of whom were well. There was
no history of previous chest pain or cardiac disease,
cough, sputum production, sweats, chills, use of tobacco
or more than moderate amounts of alcohol, intravenous
drug use, receipt of transfusions, rash, visual problems,
headache, arthralgia, or myalgia. There was no history of
recent travel, past tuberculous infection, or close contact
with anyone with tuberculosis.
On admission, he was ill-looking and in considerable
discomfort. His temperature was 38.35°C, his heart rate
was 110 beats per minute, his respiratory rate was 30
breaths per minute, and his blood pressure 110/75mmHg.
A physical examination revealed diffuse crackles in both
lungs, while no friction rub was detected. There were also
lesions consistent with Kaposi’s sarcoma on the oral mu-
cous membrane and on his lower extremities. Multiple
mobile lymph nodes of 1-cm diameter were palpated in
both axillas, whilst no additional lymph nodes were felt. A
specimen of arterial blood, drawn while he was breathing
room air, disclosed that the partial pressure of oxygen
(PaO2) was 77mmHg, the partial pressure of carbon diox-
ide (PaCO2) was 33mmHg, and the pH was 7.46. His
hematocrit level was 33.0%, his hemoglobin level was 11g/
dL (mean corpuscular volume was 85), his white cell
count was 6.13×109/L with 71.70% neutrophils, 16.50%
lymphocytes, and 8.30% monocytes, and his platelet count
was 150×109/L. His erythrocyte sedimentation rate was
50mm per hour and his C-reactive protein level was
7.00mg/dL (normal limit <0.5mg/dL). The results of
his other laboratory tests were normal except for lowhy scan (b) of our patient at admission demonstrating bilateral
at the lingula.
Figure 2 Gram stain performed from positive blood culture vial
revealing the presence of Gram-variable pleomorphic, coccoid,
and bacillary bacteria.
Figure 3 Subculture of positive blood culture vial onto solid
media. Colonies are irregularly round, smooth, semitransparent, and
mucoid, with a salmon-pink color that appeared on the fourth day
of incubation at 30°C.
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HIV-1 RNA was 71,045 copies/mL.
A microscopic examination of the stained sputum
showed AFB and a cytologic examination revealed no
malignant tumor cells. A culture of sputum specimens
yielded normal respiratory tract flora. Specimens were
subsequently inoculated onto Löwenstein-Jensen (L-J)
medium. The initial viral serology tests performed on
day two (including cytomegalovirus [CMV], coxsackie,
Epstein-Barr virus, hepatitis A, B, and C viruses, herpes
simplex virus [HSV] 1 and 2, and varicella zoster virus)
were negative except from CMV immunoglobulin G (IgG).
Based on these initial microbiological results, a possible
diagnosis of MTB infection was presumed, and anti-ΤΒ
treatment was initiated (isoniazid 5mg/kg/d, rifampicin
600mg/d, pyrazinamide 30mg/kg/d, and ethambutol 20mg/
kg/d), in combination with empirical antimicrobial treat-
ment for common bacterial pathogens (ceftriaxone 2gr/d
and moxifloxacin 400mg/d) and prophylaxis with co-
trimoxazole (1 tablet at 960mg, three times per week) and
azithromycin (2 tablets totaling 1200mg/week). Five days
later a marked increase of liver function was noted and the
rifampicin was discontinued. He developed CMV antigene-
mia (pp65 positive) and therapy with ganciclovir (5mg/kg
twice daily) was started. Subsequently, he developed neu-
tropenia and his ganciclovir dosage was adjusted. Because
of his low CD4 count, combined antiretroviral therapy
(emtricitabine 600mg/d, tenofovir 200mg/d, and efavirenz
245mg/d) was introduced within two weeks from his ad-
mission. A repeated radiograph and thoracic computed
tomography scan disclosed deterioration of pulmonary
infiltrates, while he continued to be febrile. Real-time poly-
merase chain reaction (RT-PCR) (MTB COBAS® TaqMan®
48 Analyzer, Roche Diagnostics, Basel, Switzerland) per-
formed directly in the clinical specimens was negative for
the presence of MTB DNA.
His respiratory status further deteriorated, but at this
time aerobic vials from routine blood cultures (FA
BacT/ALERT® and FN BacT/ALERT®, bioMérieux, Marcy
l’Etoile, France) collected during his hospitalization
showed as positive for microbial growth. Gram stain
from the positive blood culture vials revealed the pres-
ence of Gram-variable pleomorphic, coccoid, and bacil-
lary bacteria (Figure 2). After 24 hours of incubation
onto MacConkey and blood agar plates, white, small
colonies had grown. After prolonged incubation (over
48 hours), the colonies became smooth, glistening, and
mucoid, had begun coalescing, and were teardrop-shaped,
and after three to four days of incubation their color
turned to salmon-pink (Figure 3). The isolated micro-
organism was catalase-positive and oxidase-negative.
Phenotypic identification as Rhodococcus equi was initially
performed by BBL GP cards (bionumber 1445000540,
Becton Dickinson Diagnostics, Franklin Lakes, New Jersey,United States), whereas, by Vitek2 Advanced Expert
System™ it was identified as Kocuria varians (bionumber
010010302000000, identification with 91% probability, bio-
Merieux). His urease test was positive, whereas, synergistic
hemolysis was observed, with one hemolysin-producing
Staphylococcus aureus strain. Susceptibility testing was
performed by the disk diffusion method and Etest [6].
The isolate was susceptible to gentamicin, rifampicin,
kanamycin, tetracycline, ciprofloxacin, vancomycin (mini-
mum inhibitory concentration, MIC: 0.75μg/mL), teico-
planin (MIC: 0.5μg/mL), linezolid (MIC: 0.125μg/mL),
imipenem (MIC: 0.19μg/mL), tigecycline (MIC: 0.094μg/
mL), and daptomycin (MIC: 0.19μg/mL), and was resist-
ant to ampicillin, cefoxitin, clindamycin, sulfamethoxa-
zole/trimethoprim.
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ing PCR followed by sequencing of 23S rDNA gene and
comparison with existing universal microbial genes’ se-
quencing data (BLAST database). Homology of 98% was
detected with the R. equi genome, verifying the initial
phenotypic identification. After diagnosis of R. equi bac-
teraemia, antibiotic treatment was adjusted and ertape-
nem combined with ciprofloxacin was administered
intravenously. Three days later he became afebrile, with
gradual improvement over the next fifteen days. Ten
days after the identification of bacteraemia, growth was
observed on the L-J medium inoculated with sputa. The
Z-N stain was positive for AFB, but their coccoid morph-
ology was not consistent with mycobacteria (Figure 4). A
subculture on conventional solid media confirmed the
presence of R. equi. Unfortunately, our patient died one
month later due to CMV pneumonia.
Discussion
R. equi (formerly Corynebacterium equi) was first iso-
lated in 1923 from suppurative pulmonary lesions in
foals [7]. The organism is present in soil in all continents
except Antarctica, thrives in freshwater and marine habi-
tats, and can live in the intestines of bloodsucking ar-
thropods [8]. In the majority of cases, R. equi is acquired
by inhalation or aerosols coming from the stool of in-
fected foals, and a strong association with exposure to
livestock or farming environments is referred [9]. The
manifestations of R. equi infection are extremely diverse,
although pulmonary infection is present in 80% of cases
and may involve nodular infiltrates, pneumonic consoli-
dation, pleural effusion, or empyema [8]. Spreading of
the infection to other organs is common, particularly in
immunocompromised subjects [10]. Bacteraemia occurs
in over 80% of immunocompromised patients [11].Figure 4 Ziehl-Neelsen stain from the Löwenstein-Jensen medium
inoculated with sputa samples. The coccoid morphology of stained
bacteria was not consistent with mycobacteria.Respiratory disease tends to follow a subacute course with
progressive cough, pleuritic chest pain, and fever often
accompanied by cachexia, weight loss, and fatigue [12].
R. equi is an asporogenous, nonmotile, Gram-positive,
obligate aerobe, growing optimally at 30°C but also at
temperatures ranging from 10°C to 40°C. Colonies form
on solid media in 48 hours or less and appear irregularly
round, smooth, semitransparent, glistening, and mucoid.
The characteristic salmon-pink color may not appear
until days four to seven [13]. The organism varies from
distinctly coccoid to bacillary, appearing coccoid on solid
media or in purulent tissue, but forming long rods or
short filaments with rudimentary branching in liquid
media [9]. R. equi is characterized by the presence of
catalase, urease, lipase, and phosphatase and by the ab-
sence of oxidase, DNAse, elastase, lecithinase, and prote-
ase [13]. Automated systems may lead to ambiguous
results, as denoted in other studies [14]. Results of acid-
fast staining are highly variable and R. equi can easily be
mistaken for Mycobacterium organisms. In a reported
case, a 56-year-old man who was HIV-seronegative was
initially diagnosed with active pulmonary tuberculosis,
and was treated with a multidrug antituberculosis regi-
men for three months despite a negative culture for
mycobacteria [15]. Sputum smears were still positive for
AFB and no clinical improvement was made until R.
equi was isolated from the sputum [15]. Acid-fastness of
Rhodococcus, along with clinical presentation and radio-
graphic findings, lead to frequent misdiagnosis as pul-
monary tuberculosis [9]. Besides R. equi, other respiratory
pathogens share the acid-fast staining ability of MTB and
NTM, and therefore, clinicians should be aware of the
potential for misdiagnosis of these organisms as myco-
bacteria or the possibility of coinfection among those
with persistently positive acid-fast staining smears.
There is no standard treatment for infection with
Rhodococcus and treatment usually consists of a combin-
ation of at least two antibiotics to which the agent is
susceptible [9]. These include macrolides, rifampicin,
fluoroquinolones, aminoglycosides, glycopeptides, and
carbapenems, although newer drugs, such as tigecycline
and linezolid, have also been successfully used [10]. Our
isolate was susceptible to rifampicin, ciprofloxacin,
aminoglycosides, glycopeptides, and carbapenems, as
expected, as well as tigecycline and linezolid, whereas
resistance to beta-lactam antibiotics was observed as
reported [9]. The choice should be based on the results
of antibiotic susceptibility testing and drugs must be
given intravenously for at least two weeks, followed by
prolonged oral suppressive antibiotic treatment, whereas,
surgical drainage of abscesses or cavitary lesions may also
be required [10].
Despite treatment, the outcome of Rhodococcus infec-
tion is poor in immunocompromised patients, with the
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tion [10]. The use of highly active antiretroviral therapy,
however, has dramatically changed the prognosis in pa-
tients with HIV, with reported survival rates of virtually
100% [10].
Conclusions
R. equi is a rare cause of pulmonary disease, even in pa-
tients with HIV, and the diagnosis may be problematic
because of a low index of suspicion and frequent mis-
identification for more common organisms such as
mycobacteria. A positive Z-N stain in the sputum speci-
men of an eligible patient should not preclude a TB
diagnosis. Besides R. equi, Nocardia spp., and Legionella
micdadei can also represent facultative pathogens, either
alone or as co-offenders. Communication between clini-
cians and the microbiology laboratory can ensure a
prompt diagnosis, early initiation of antimicrobial and
antiretroviral treatment, and a favorable outcome.
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